On March 4, 2021 Cancer Genetics, Inc. (the "Company") (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, reported that Jay Roberts, Chief Executive Officer, will present at H.C. Wainwright’s Global Life Sciences Conference (Press release, Cancer Genetics, MAR 4, 2021, View Source [SID1234576091]). The event is being held virtually from March 9-10, 2021.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conference Date: March 9-10, 2021 (Tuesday-Wednesday)
On-Demand Starts: 7:00 am ET – Tuesday, March 9, 2021
On-Demand Ends 7:00 pm ET- Wednesday, March 10, 2021
Registration: View Source
Mr. Roberts will highlight the Company’s recent transformational business strategy, including the Company’s proposed merger with StemoniX, Inc., and elaborate on the broader going- forward corporate vision.
If you are an institutional investor and would like to attend the Company’s presentation, please click on the following link (View Source) to register for the H.C. Wainwright Global Life Sciences Conference. Once your registration is confirmed, you will be prompted to log into the conference website and will be able to request a one-on-one meeting with the Company.
Cancer Genetics will also be available for virtual outside 1:1 meetings both during and after the H.C. Wainwright Global Life Sciences Conference. Please contact Jennifer K. Zimmons, Ph.D. jzimmons@zimmonsic.com 917.214.3514 for scheduling.